Skip Navigation


International Immunology Advance Access originally published online on January 14, 2008
International Immunology 2008 20(3):337-343; doi:10.1093/intimm/dxm147
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
20/3/337    most recent
dxm147v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Suzue, K.
Right arrow Articles by Koyasu, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suzue, K.
Right arrow Articles by Koyasu, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Japanese Society for Immunology. 2008. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Critical role of dendritic cells in determining the Th1/Th2 balance upon Leishmania major infection

Kazutomo Suzue1,2, Seiki Kobayashi3, Tsutomu Takeuchi3, Mamoru Suzuki2 and Shigeo Koyasu1,4

1 Department of Microbiology and Immunology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
2 Department of Parasitology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan
3 Department of Tropical Medicine and Parasitology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
4 Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation, Kawaguchi 332-0012, Japan

Correspondence to: S. Koyasu; E-mail: koyasu{at}sc.itc.keio.ac.jp

The onset of Th1 immunity is in part regulated by genetic background. To elucidate the cell type carrying critical factors determining the Th1 response, we employed Rag-2–/– mice on Leishmania major-susceptible BALB/c and -resistant B10.D2 backgrounds. By using bone marrow (BM) chimeras generated by the transplantation of B10.D2 BM cells into BALB/c-Rag-2–/– mice, and vice versa, it was shown that hematopoietic cells carry factors determining the disease outcome and Th1 response against L. major infection. B10.D2-Rag-2–/– mice reconstituted with BALB/c CD4+ T cells exhibited a Th1 response and controlled L. major infection. Wild-type BALB/c mice inoculated with L. major-parasitized B10.D2-Rag-2–/– splenocytes also exhibited a Th1 response and a mild disease outcome, whereas such a Th1 response was not induced when CD11c+ dendritic cells (DCs) were depleted from parasitized B10.D2-Rag-2–/– splenocytes. Th1 response was reconstituted by the addition of L. major-parasitized B10.D2 DCs but not L. major-parasitized BALB/c DCs to DC-depleted parasitized B10.D2-Rag-2–/– splenocytes. These results indicate that DCs determine the outcome of the disease upon L. major infection.

Keywords: antigen-presenting cell, infectious disease, protozoan parasite, Th

Transmitting editor: K. Inaba

Received 23 September 2007, accepted 12 December 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 BloodHome page
M. Ohtani, S. Nagai, S. Kondo, S. Mizuno, K. Nakamura, M. Tanabe, T. Takeuchi, S. Matsuda, and S. Koyasu
Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells
Blood, August 1, 2008; 112(3): 635 - 643.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.